COVID-19 in Polish Ice Swimmers. (ICE)
6 april 2021 uppdaterad av: Wroclaw Medical University
Influence of Ice Swimming on Hardening Against SARS-CoV-2 and Influence of AB0 Rh Blood Type on Viral Resistance in Polish Ice Swimmers.
Ice swimming is an increasingly common phenomenon in Poland.
It has been confirmed that it has a beneficial effect on health by increasing the natural non-specific immunity to infections.
In the face of the current Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic causing Coronavirus Disease 2019 (COVID-19), researchers decided to use a survey to check the incidence of COVID-19 among Polish ice swimmers, as well as recent ailments.
Then, the researchers will compare the obtained results with epidemiological data for Poland.Researchers will also investigate the relationship between susceptibility to SARS-CoV-2 infection and the blood group and Rh factor among ice swimmers.
Studieöversikt
Status
Avslutad
Intervention / Behandling
Detaljerad beskrivning
The research tool is an original questionnaire compiled by a team of experts conducting the study. The survey includes questions about sociodemographic data, such as age and gender and blood type in AB0 system with Rh factor, and questions about the frequency of ice swimming, the duration of a single session, and since when respondents have been ice swimming. There was also a question about the respondents' compliance with the restrictions and recommendations related to the pandemic and contacts with people with confirmed SARS-CoV-2 infection. In the survey, researchers ask about the infectious symptoms experienced during the pandemic and about being diagnosed with COVID-19 or its exclusion. People who have been ill are asked about the place of treatment.
The questionnaires are collected in traditional form, on the Internet and as scans of documents. Each survey was completely anonymous. The obtained statistical data will be compared with official data on new COVID-19 cases and recoveries at the same time. Official data are published by the Ministry of Health and earlier also by Sanitary and Epidemiological Stations. The main aim of the study was to determine whether ice swimming also increases resistance to SARS-CoV-2 and COVID-19.
Studietyp
Observationell
Inskrivning (Faktisk)
2534
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Dolny Slask
-
Wrocław, Dolny Slask, Polen, 51-618
- Department of Public Health at Wroclaw Medical University
-
-
Lubuskie
-
Gorzów Wielkopolski, Lubuskie, Polen, 66-400
- Department of Radiotherapy of Multidisciplinary Provincial Hospital
-
Zielona Góra, Lubuskie, Polen, 65-031
- Treasury Medical Company
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Barn
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Ja
Kön som är behöriga för studier
Allt
Testmetod
Icke-sannolikhetsprov
Studera befolkning
Surveys are distributed en masse among ice swimmers from Poland.
Comparative data for the control group is derived from officially published national and regional pandemic data.
Beskrivning
Inclusion Criteria:
- ice swimmers
Exclusion Criteria:
- not active ice swimmers
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
Ice Swimmers Group.
No intervention.
Data obtained from Polish ice swimmers reported by them retrospectively in the questionnaire.
|
The intervention is not made in the course of a research study.
Ice swimming has been introduced earlier by a given group.
The group was made up of people who already swim in ice.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Assessment of the incidence of COVID-19 among ice swimmers compared to the general population.
Tidsram: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
|
Assessment of the frequency of asymptomatic SARS-CoV-2 infection among ice swimmers compared to the general population.
Tidsram: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
|
Assessment of the frequency of occurrence of particular symptoms of SARS-CoV-2 infection among ice swimmers compared to the general population.
Tidsram: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
|
Assessment of the frequency of COVID-19 treatment in an outpatient, inpatient and intensive care unit among ice swimmers compared to the general population.
Tidsram: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
|
Assessment of the impact of parameters and ice swimming strategies on the likelihood of developing COVID-19, the occurrence of individual symptoms of the disease and the severity of its course.
Tidsram: 47 days.
|
Inference from data obtained from surveys collected among ice swimmers.
|
47 days.
|
|
Assessment of the influence of blood group on susceptibility to SARS-CoV-2 infection among ice swimmers.
Tidsram: 47 days.
|
Inference from data obtained from surveys collected among ice swimmers.
|
47 days.
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Assessment of the immunity of the ice swimmer's immune system compared to the general population.
Tidsram: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Utredare
- Studierektor: Sylwia Sulimiera Michalak, MD, PhD, Department of Pharmacology and Toxicology, Medical University of Zielona Gora
- Studierektor: Edyta Wolny-Rokicka, MD, PhD, Department and Center of Radiotherapy, Multidisciplinary Provincial Hospital in Gorzow Wielkopolski
- Studiestol: Andrzej Tukiendorf, Prof., Department of Public Health, Wroclaw Medical University
- Huvudutredare: Lukasz K Wysoczanski, MD, Department of Family Medicine, Wroclaw Medical University
- Huvudutredare: Paulina N Wysoczanska, MD, Department of Family Medicine, Wroclaw Medical University
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
1 december 2020
Primärt slutförande (Faktisk)
17 januari 2021
Avslutad studie (Faktisk)
1 mars 2021
Studieregistreringsdatum
Först inskickad
24 mars 2021
Först inskickad som uppfyllde QC-kriterierna
25 mars 2021
Första postat (Faktisk)
26 mars 2021
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
9 april 2021
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
6 april 2021
Senast verifierad
1 april 2021
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
- Patologiska processer
- Coronavirusinfektioner
- Coronaviridae-infektioner
- Nidovirales infektioner
- RNA-virusinfektioner
- Virussjukdomar
- Infektioner
- Luftvägsinfektioner
- Luftvägssjukdomar
- Lunginflammation, Viral
- Lunginflammation
- Lungsjukdomar
- Sjukdomsegenskaper
- Förändringar i kroppstemperaturen
- Svår akut respiratorisk sjukdom
- Covid-19
- Hypotermi
- Sjukdomsresistens
Andra studie-ID-nummer
- KB-03/139/2021
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .